Gregory Fulcher

4.1k total citations · 1 hit paper
74 papers, 2.3k citations indexed

About

Gregory Fulcher is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Gregory Fulcher has authored 74 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Surgery and 15 papers in Epidemiology. Recurrent topics in Gregory Fulcher's work include Diabetes Management and Research (33 papers), Diabetes Treatment and Management (29 papers) and Pancreatic function and diabetes (13 papers). Gregory Fulcher is often cited by papers focused on Diabetes Management and Research (33 papers), Diabetes Treatment and Management (29 papers) and Pancreatic function and diabetes (13 papers). Gregory Fulcher collaborates with scholars based in Australia, United Kingdom and United States. Gregory Fulcher's co-authors include E. G. Wilmshurst, Mark Walker, K. G. M. M. Alberti, Carlo Catalano, Bruce Neal, Sophia Zoungas, M. Farrer, Jonathan Thow, Dennis K. Yue and Emma Scott and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Gregory Fulcher

73 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes

2017 305 citations Gregory Fulcher et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gregory Fulcher Australia	26	1.5k	641	403	340	308	74	2.3k
Soon Jib Yoo South Korea	26	1.3k 0.9×	1.1k 1.7×	505 1.3×	443 1.3×	497 1.6×	106	2.7k
Cristiane Bauermann Leitão Brazil	30	1.2k 0.8×	933 1.5×	330 0.8×	496 1.5×	272 0.9×	125	2.8k
Ee Mun Lim Australia	28	1.4k 0.9×	575 0.9×	398 1.0×	374 1.1×	445 1.4×	88	2.8k
K. C. B. Tan Hong Kong	30	1.3k 0.8×	725 1.1×	475 1.2×	462 1.4×	174 0.6×	90	2.9k
Donald A. Bergman United States	15	803 0.5×	459 0.7×	353 0.9×	358 1.1×	149 0.5×	21	1.9k
Gareth Dunseath United Kingdom	23	1.0k 0.7×	462 0.7×	287 0.7×	307 0.9×	316 1.0×	77	1.8k
Roberto Miccoli Italy	31	1.4k 0.9×	828 1.3×	586 1.5×	332 1.0×	236 0.8×	124	3.5k
Deep Dutta India	27	1.1k 0.7×	440 0.7×	388 1.0×	420 1.2×	197 0.6×	247	2.6k
Silvia Manfrini Italy	35	1.2k 0.8×	964 1.5×	481 1.2×	733 2.2×	637 2.1×	104	3.4k
Hillary A. Keenan United States	25	1.0k 0.7×	689 1.1×	294 0.7×	295 0.9×	739 2.4×	66	2.0k

Countries citing papers authored by Gregory Fulcher

Since Specialization

Citations

This map shows the geographic impact of Gregory Fulcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Fulcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Fulcher more than expected).

Fields of papers citing papers by Gregory Fulcher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Fulcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Fulcher. The network helps show where Gregory Fulcher may publish in the future.

Co-authorship network of co-authors of Gregory Fulcher

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Fulcher. A scholar is included among the top collaborators of Gregory Fulcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Fulcher. Gregory Fulcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zimbudzi, Edward, Clement Lo, Sanjeeva Ranasinha, et al.. (2023). A codesigned integrated kidney and diabetes model of care improves patient activation among patients from culturally and linguistically diverse backgrounds. Health Expectations. 26(6). 2584–2593. 4 indexed citations

Rabbani, Naila, Antonysunil Adaikalakoteswari, James R. Larkin, et al.. (2022). Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease. International Journal of Molecular Sciences. 24(1). 152–152. 16 indexed citations

Zimbudzi, Edward, Clement Lo, Sanjeeva Ranasinha, et al.. (2021). A co-designed integrated kidney and diabetes model of care improves mortality, glycaemic control and self-care. Nephrology Dialysis Transplantation. 37(8). 1472–1481. 5 indexed citations

Fulcher, Gregory, et al.. (2021). ARISE—a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in real-world settings: rationale and design. Endocrine. 74(3). 530–537. 5 indexed citations

Scott, Emma, Andrzej S. Januszewski, Luke Carroll, et al.. (2021). Continuous subcutaneous insulin infusion alters microRNA expression and glycaemic variability in children with type 1 diabetes. Scientific Reports. 11(1). 16656–16656. 3 indexed citations

Scott, Emma, Rachel T. McGrath, Andrzej S. Januszewski, et al.. (2019). HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment. BMJ Open. 9(12). e033059–e033059. 17 indexed citations

Bethel, M. Angelyn, Kristen A. Hyland, Antônio Roberto Chacra, et al.. (2017). Updated risk factors should be used to predict development of diabetes. Journal of Diabetes and its Complications. 31(5). 859–863. 4 indexed citations

Zimbudzi, Edward, Clement Lo, Sanjeeva Ranasinha, et al.. (2017). Factors associated with patient activation in an Australian population with comorbid diabetes and chronic kidney disease: a cross-sectional study. BMJ Open. 7(10). e017695–e017695. 46 indexed citations

McGrath, Rachel T., Samantha Hocking, Miriam Priglinger, et al.. (2016). Rationale and design of Short-Term EXenatide therapy in Acute ischaemic Stroke (STEXAS): a randomised, open-label, parallel-group study. BMJ Open. 6(2). e008203–e008203. 10 indexed citations

10.

Fulcher, Gregory, Anthony Roberts, Ashim Sinha, & Joseph Proietto. (2015). What happens when patients require intensification from basal insulin? A retrospective audit of clinical practice for the treatment of type 2 diabetes from four Australian centres. Diabetes Research and Clinical Practice. 108(3). 405–413. 10 indexed citations

11.

Fulcher, Gregory, et al.. (2014). The psychosocial and financial impact of non-severe hypoglycemic events on people with diabetes: two international surveys. Journal of Medical Economics. 17(10). 751–761. 50 indexed citations

12.

Xu, Shaoyong, Neale Cohen, Maria E. Craig, et al.. (2014). Healthcare professional requirements for the care of adult diabetes patients managed with insulin pumps in Australia. Internal Medicine Journal. 45(1). 86–93. 11 indexed citations

13.

Bethel, M. Angelyn, Antônio Roberto Chacra, Prakash Deedwania, et al.. (2013). A Novel Risk Classification Paradigm for Patients With Impaired Glucose Tolerance and High Cardiovascular Risk. The American Journal of Cardiology. 112(2). 231–237. 4 indexed citations

14.

Zoungas, Sophia, John Chalmers, Toshiharu Ninomiya, et al.. (2011). Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia. 55(3). 636–643. 265 indexed citations

15.

Scott, Russell, Mark W. Donoghoe, Gerald F. Watts, et al.. (2011). Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial. Cardiovascular Diabetology. 10(1). 102–102. 44 indexed citations

16.

Clifton‐Bligh, P., et al.. (2000). Bone Density and Body Composition in Young Women with Chronic Fatigue Syndrome. Annals of the New York Academy of Sciences. 904(1). 625–627. 5 indexed citations

17.

Farrer, M., Gregory Fulcher, Alison Johnson, C O Record, & K. G. M. M. Alberti. (1992). Effect of acute inhibition of lipolysis on operation of the glucose-fatty acid cycle in hepatic cirrhosis. Metabolism. 41(5). 465–470. 18 indexed citations

18.

Fulcher, Gregory, et al.. (1991). A comparison of measurements of lean body mass derived by bioelectrical impedance, skinfold thickness and total body potassium. A study in obese and non-obese normal subjects. Scandinavian Journal of Clinical and Laboratory Investigation. 51(3). 245–253. 34 indexed citations

19.

Thow, Jonathan, A.B. Johnson, Gregory Fulcher, & Philip Home. (1990). Different Absorption of Isophane (NPH) Insulin from Subcutaneous and Intramuscular Sites Suggests a Need to Reassess Recommended Insulin Injection Technique. Diabetic Medicine. 7(7). 600–602. 38 indexed citations

20.

Catalano, Carlo, Maurizio Postorino, Peter J. Kelly, et al.. (1990). Diabetes Mellitus and Renal Replacement Therapy in Italy: Prevalence, Main Characteristics and Complications. Nephrology Dialysis Transplantation. 5(9). 788–796. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact